Clinical utility of nanopore-targeted sequencing for diagnosing and treating pulmonary infectious diseases from bronchoalveolar lavage fluid

被引:0
|
作者
Li, Gen [1 ]
Sun, He [2 ]
Ye, Yangqin [1 ]
Chen, Liqiong [1 ]
Zhang, Wenyan [1 ]
Yu, Shanshan [1 ]
Li, Qiang [2 ]
Fan, Lieying [1 ]
机构
[1] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Clin Lab, Shanghai, Peoples R China
[2] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Resp & Crit Care Med, Shanghai, Peoples R China
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2025年 / 15卷
基金
中国国家自然科学基金;
关键词
conventional microbial testing; nanopore-targeted sequencing; pulmonary infectious diseases; bronchoalveolar lavage fluid; diagnostic;
D O I
10.3389/fcimb.2025.1469440
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Conventional microbial testing (CMTs) for infectious pathogens faces challenges in rapid and comprehensive detection. Nanopore-targeted sequencing (NTS) is a novel approach for rapid identification of pathogens; however, clinical experience with the application of NTS is limited. Methods: We evaluated the diagnostic value of NTS for detecting microbes in bronchoalveolar lavage fluid samples in patients with pulmonary infectious disease (PID, 137 cases), non-pulmonary infectious disease (NPID, 32 cases), or with an unknown etiology (11 cases). We performed a comparative analysis of the diagnostic efficacy of NTS and CMTs in identifying pulmonary infectious diseases and investigated the clinical utility of NTS as a diagnostic tool. Results: NTS was significantly more sensitive than CMTs in detecting PID (86.13% vs 67.15%, P < 0.01), particularly for important specific pathogens. There were no significant differences between NTS and CMTs in terms of specificity, positive predictive value or negative predictive value. Moreover, NTS (not CMTs) detected 56 microorganisms consistent with clinical presentation, indicating that NTS can provide clinicians with additional support for infection diagnosis. Additionally, prior antibiotic exposure had no influence on the detection efficiency of NTS but significantly hindered that of CMTs. After antibiotic adjustments based on NTS findings, 87.76% of patients showed significant improvement, with a notable decrease in the level of inflammatory markers (CRP, NP, PCT, WBC) post-treatment. Furthermore, NTS can significantly shorten turnaround time and provide real-time results for rapid decision making. Conclusions: NTS is more efficient than CMTs in diagnosing pulmonary infectious diseases, particularly in detecting critical or specific pathogens, providing faster and more accurate clinical information even for patients with prior antibiotic exposure. Moreover, NTS can assist clinicians in formulating more effective anti-infection strategies.
引用
收藏
页数:13
相关论文
共 37 条
  • [1] Clinical application of nanopore-targeted sequencing technology in bronchoalveolar lavage fluid from patients with pulmonary infections
    Ye, Jiayuan
    Huang, Kai
    Xu, Yaojiang
    Chen, Nan
    Tu, Yifei
    Huang, Jing
    Shao, Longfei
    Kong, Weiliang
    Zhao, Dongdong
    Xie, Yilian
    MICROBIOLOGY SPECTRUM, 2024, 12 (06):
  • [2] Clinical Performance of Nanopore Targeted Sequencing for Diagnosing Infectious Diseases
    Fu, Yu
    Chen, Qingsong
    Xiong, Mengyuan
    Zhao, Jin
    Shen, Shucheng
    Chen, Liangjun
    Pan, Yunbao
    Li, Zhiqiang
    Li, Yirong
    MICROBIOLOGY SPECTRUM, 2022, 10 (02):
  • [3] Diagnostic value of a nanopore sequencing assay of bronchoalveolar lavage fluid in pulmonary tuberculosis
    Liu, Zhifeng
    Yang, Yang
    Wang, Qingfeng
    Wang, Lei
    Nie, Wenjuan
    Chu, Naihui
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [4] Diagnostic value of a nanopore sequencing assay of bronchoalveolar lavage fluid in pulmonary tuberculosis
    Zhifeng Liu
    Yang Yang
    Qingfeng Wang
    Lei Wang
    Wenjuan Nie
    Naihui Chu
    BMC Pulmonary Medicine, 23
  • [5] Utility of nanopore sequencing for detecting pathogens in bronchoalveolar lavage fluid from pediatric patients with respiratory failure
    Yamaguchi, Makoto
    Horiba, Kazuhiro
    Haruta, Kazunori
    Takeuchi, Suguru
    Suzuki, Takako
    Torii, Yuka
    Kawabe, Shinji
    Wada, Sho
    Ikeyama, Takanari
    Ito, Yoshinori
    Ogi, Tomoo
    Kawada, Jun-ichi
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2023, 3 (02):
  • [6] A preliminary evaluation of targeted nanopore sequencing technology for the detection of Mycobacterium tuberculosis in bronchoalveolar lavage fluid specimens
    Sun, Xiaoke
    Song, Jingchao
    Leng, Xia
    Li, Fuli
    Wang, Haojie
    He, Jiaqian
    Zhai, Wenhua
    Wang, Zhenjing
    Wu, Qingqing
    Li, Zheng
    Ruan, Xianglin
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [7] THE DIAGNOSIS VALUE OF BRONCHOALVEOLAR LAVAGE DETECTION BY HIGH-THROUGHPUT SEQUENCING FOR PULMONARY INFECTIOUS DISEASES
    Feng, Dingyun
    Li, Ying
    Jiang, Zhiyi
    Wang, Yanhong
    Zhou, Yuqi
    Zhang, Tiantuo
    RESPIROLOGY, 2018, 23 : 329 - 329
  • [8] The application of nanopore targeted sequencing for pathogen diagnosis in bronchoalveolar lavage fluid of patients with pneumonia: a prospective multicenter study
    Lin, Qinqing
    Yao, Yake
    Li, Xi
    Zhang, Shanshan
    Guo, Huimin
    Ma, Xiaolong
    Chen, Wenyu
    Ru, Chuhui
    Wang, Limin
    Wang, Bin
    Ma, Qiang
    Zhu, Junfei
    Lin, Xuemei
    Chen, Qi
    Lou, Hui
    Chen, Junjun
    Zeng, Zhu
    Zhou, Jianying
    Chen, Yan
    Yu, Yunsong
    Zhou, Hua
    INFECTIOUS DISEASES, 2024, 56 (02) : 128 - 137
  • [9] Application of Targeted Next-Generation Sequencing in Bronchoalveolar Lavage Fluid for the Detection of Pathogens in Pulmonary Infections
    Dai, Xianning
    Xu, Kai
    Tong, Yu
    Li, Jing
    Dai, Liya
    Shi, Jianyou
    Xie, Haibin
    Chen, Xi
    INFECTION AND DRUG RESISTANCE, 2025, 18 : 511 - 522
  • [10] Determination of the diagnostic accuracy of nanopore sequencing using bronchoalveolar lavage fluid samples from patients with sputum-scarce pulmonary tuberculosis
    Zhou, Lihong
    Zou, Xingwu
    Hu, Qin
    Hua, Haibo
    Qi, Qi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (02) : 98 - 103